[1] |
ZHONG Wei, SHI Shuxia, QIN Qinyue, YU Guo.
Measurement tools and rationality evaluation of clinical research coordinator's work ability and workload
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(8): 937-947.
|
[2] |
MIAO Yadong, LI Xi, WANG Yan, GAO Po, ZHOU Min, YU Hao.
General considerations for clinical data management of antineoplastic drugs
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(9): 1055-1060.
|
[3] |
JIANG Haihong, LI Xiao, LIU Yang.
Four dimensions of receiving overseas clinical trial data about drug and medical devices
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(7): 835-840.
|
[4] |
LI Qingna, HUANG Ke, LU Fang, ZHAO Yang, QIU Panbo, WANG Shuge, GAO Rui.
Characteristic and development of standard operating procedure of electronic data management in traditional Chinese medicine clinical research
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(5): 550-554.
|
[5] |
GUO Wei, XIE Linli, CAO Liya, XIE Jiangchuan, XIA Peiyuan, CHEN Yongchuan.
Analysis of the current status of clinical drug trial institutions in Chongqing and reflections on the establishment of regional institutions
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(10): 1125-1130.
|
[6] |
CHE Jinjing.
Application of biomarkers in clinical development of biologics and bioanalytical strategies
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(1): 22-31.
|
[7] |
CHANG Qingqing, PENG Ying, WANG Guangji, SUN Jianguo.
Clinical research progress of small molecule tyrosine kinase inhibitors as anti-hepatocellular carcinoma agents
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2019, 24(8): 948-956.
|
[8] |
XIAO Liang, ZHENG Gaozhe, HUANG Yumin.
Research progress on risk-based management in clinical trials
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2017, 22(8): 955-960.
|
[9] |
SHAN Jiao-jiao,TANG Yi-qun,SHI Mei-qi, XIA Guo-hao, WANG Li,FANG Ying,ZHAO Jie.
Impact of clinical pharmacists on protocol deviation in anti-cancer drug clinical trial
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2014, 19(1): 33-37.
|
[10] |
WANG Hui, HU Si-yuan.
Clinical research design technical points on child anorexia treated by new TCM drugs
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2012, 17(10): 1191-1195.
|
[11] |
LI Hai-gang, XIE Hai-tang, YANG Guo-ping, SUN Hua, PAN Hang-shan.
Explore of data management model of early intervention in clinical trials
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2011, 16(10): 1142-1147.
|
[12] |
GUO Jun-hao, LIU Yu-xiu, CAI Hui.
Implement of timing function when incoming data with EpiData
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2008, 13(7): 792-795.
|
[13] |
GUO Jun-hao, LIU Yu-xiu, CAI Hui.
Ways of logical check in data management with EpiData
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2008, 13(5): 541-544.
|
[14] |
BO Qing-yan, XIONG Ning-ning, ZOU Jian-dong, JIANG Meng, LIU Fang, WANG Xiu-qin, GAO Wei-min.
Electronic data capture:achieving the promise of more efficient and higher quality clinical trials
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2007, 12(4): 455-459.
|
[15] |
.
Key activities involved in conduct of clinical trials
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2006, 11(3): 357-360.
|